Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

July 10, 2020

Study Completion Date

May 31, 2021

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
COMBINATION_PRODUCT

Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants

60% of participants will take 3-4 capsules of broad spectrum micronutrients three times per day for eight weeks. Following the initial 8 weeks (of the RCT), all participants will have the option to participate in an open label extension, during which time the child would take the active micronutrient treatment for 8 weeks

DIETARY_SUPPLEMENT

Placebo

40% of participants will take 3-4 capsules of inactive placebo three times per day for eight weeks.

Trial Locations (3)

43210

The Ohio State University, Columbus

97239

Oregon Health & Science University, Portland

AB T1K 6T5

University of Lethbridge, Lethbridge

All Listed Sponsors
collaborator

Ohio State University

OTHER

collaborator

University of Lethbridge

OTHER

collaborator

National University of Natural Medicine

OTHER

collaborator

Foundation for Excellence in Mental Health Care

OTHER

collaborator

The Waterloo Foundation

OTHER

lead

Oregon Health and Science University

OTHER

NCT03252522 - Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study | Biotech Hunter | Biotech Hunter